Study: Herpes Zoster Patients Experience Intense Pain; polyDNA Reviews Medical Studies
Rochester, NY (PRWEB) June 25, 2014 -- Postherpetic neuralgia (PHN) is the most common symptom of herpes zoster (shingles). (See Patient.co.uk, last checked February 5, 2013) (2) “Many patients do not understand why their pain lasts after the rash has healed. Some fear that they are imagining the symptoms or that their complaints represent a weakness in character. Patients should be reassured that their symptoms are real and represent the unseen and persistent damage to the sensory nerves.” (3)
“Herpes zoster (HZ), commonly called shingles, is a distinctive syndrome caused by reactivation of varicella zoster virus (VZV). This reactivation occurs when immunity to VZV declines because of aging or immunosuppression (a weakened immune system). Herpes zoster can occur at any age but most commonly affects the elderly population. Postherpetic neuralgia (PHN), defined as pain persisting more than 3 months after the rash has healed, is a debilitating and difficult to manage consequence of HZ.” (See Mayo Clinic Proceedings, from March 2009) (3)
polyDNA recommends that people with a VZV infection take Novirin or Gene-Eden-VIR. The formula of these natural antiviral products was tested by Hanan Polansky and Edan Itzkovitz from the CBCD in two clinical studies that followed FDA guidelines. The studies showed that the Novirin and Gene-Eden-VIR formula is effective against latent viruses. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, “individuals infected with the (herpes and other viruses)…reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR.” (4) The study authors also wrote that, “We observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (4)
Both products can be ordered online on the Novirin and Gene-Eden-VIR websites.
Novirin and Gene-Eden-VIR are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Gene-Eden-VIR and Novirin are the only natural antiviral products on the market with published clinical studies that support their claims.
“Postherpetic neuralgia is a debilitating complication of HZ. The risk of PHN after HZ increases with age. In a large population-based study, the rate of PHN (defined as at least 90 days of documented pain) increased from 5% in those younger than 60 years to 10% in those aged 60 to 69 years and to 20% in those aged 80 years or older. The pain results in large part from damage to the sensory nerves, causing neuropathic pain (3).”
“We recommend that individuals infected with a latent virus like VZV take Novirin or Gene-Eden-VIR. The formula of these natural antivirals was designed to help the immune system target the latent virus.” - Mike Evans, polyDNA
To learn more about Novirin, visit http://www.novirin.com. To learn more about Gene-Eden-VIR, visit: http://www.gene-eden-vir.com. All orders are completely confidential, and no information is shared or sold to any third party. Privacy is assured.
References:
(1) Burden of post-herpetic neuralgia in a sample of UK residents aged 50 years or older: findings from the zoster quality of life (ZQOL) study. Published in June 2014.
http://www.ncbi.nlm.nih.gov/pubmed/24920439
(2) Patient.co.uk - Postherpetic Neuralgia. Last checked on February 5, 2013.
http://www.patient.co.uk/doctor/postherpetic-neuralgia-pro
(3) Herpes Zoster (Shingles) and Postherpetic Neuralgia. Published in March 2009. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664599/
(4) Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published in September 2013.
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101#.U056hVWSz90
Mike Davis, PolyDNA, http://gene-eden-kill-virus.com/, +1 5852509999, [email protected]
Share this article